Anixa Biosciences (ANIX) Total Debt (2010 - 2017)

Anixa Biosciences (ANIX) has reported Total Debt for 6 consecutive years, with $2.0 million the latest figure, recorded in Q3 2017.

• For the quarter ending Q3 2017, Total Debt changed N/A year-over-year to $2.0 million; the trailing twelve-month figure through Jul 2017 stood at $2.0 million (changed N/A YoY), and the FY2014 full-year result was $1.0 million, down 81.37% from the prior year.
• Total Debt fell to $2.0 million in Q3 2017 per ANIX's latest filing, from $3.0 million in the prior quarter.
• Across five years, Total Debt topped out at $6.2 million in Q1 2013 and bottomed at $1.0 million in Q4 2014.
• Historically, Total Debt has averaged $4.6 million across 3 years, with a median of $5.5 million in 2013.
• The sharpest annual moves came in 2013 and 2014: Total Debt advanced 23.6% in 2013, then slumped 81.37% in 2014.
• Over 3 years, Total Debt stood at $5.5 million in 2013, then plunged by 81.37% to $1.0 million in 2014, then surged by 93.8% to $2.0 million in 2017.
• According to Business Quant data, Total Debt over the past three periods registered $2.0 million, $3.0 million, and $6.0 million for Q3 2017, Q2 2017, and Q1 2017 respectively.